Researcher
Ashenafi Shiferaw Bulle
- Disciplines:Morphological sciences, Oncology
Affiliations
- Clinical Digestive Oncology (Division)
Member
From22 May 2017 → 30 Jun 2019 - Hepatology (Division)
Member
From1 Oct 2013 → 21 May 2017
Publications
1 - 6 of 6
- Gemcitabine induces Epithelial-to-Mesenchymal Transition in patient-derived pancreatic ductal adenocarcinoma xenografts(2019)
Authors: Ashenafi Shiferaw Bulle, Jeroen Dekervel, Louis Libbrecht, David Nittner, Eric Van Cutsem, Chris Verslype, Jos van Pelt
Pages: 765 - 779 - Relevance of the stroma in pancreatic ductal adenocarcinoma and its challenges for translational research(2017)
Authors: Ashenafi Shiferaw Bulle, Jeroen Dekervel, Schalk Van der Merwe, Eric Van Cutsem, Chris Verslype
Pages: 1 - 15 - Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response(2017)
Authors: Jeroen Dekervel, Ashenafi Shiferaw Bulle, Diether Lambrechts, Eric Van Cutsem, Chris Verslype, Jos van Pelt
Pages: 59 - 69 - The old antibiotic acriflavine inhibits epithelial-to-mesenchymal transition and the unfolded protein response thereby resensitizing resistant hepatoma cells to sorafenib(2016)
Authors: Jeroen Dekervel, Ashenafi Shiferaw Bulle, Petra Windmolders, Diether Lambrechts, Eric Van Cutsem, Chris Verslype
Pages: 245 - A Global Risk Score (GRS) to simultaneously predict early and late tumor recurrence risk after resection of hepatocellular carcinoma(2016)
Authors: Jeroen Dekervel, Dusan Popovic, Hannah van Malenstein, Louis Libbrecht, Ashenafi Shiferaw Bulle, Bart De Moor, Eric Van Cutsem, Frederik Nevens, Chris Verslype, Jos van Pelt
Pages: 139 - 146 - A GLOBAL RISK GENE SCORE PREDICTS EARLY AND LATE TUMOR RECURRENCE AFTER RESECTION OF HEPATOCELLULAR CARCINOMA(2015)
Authors: Jeroen Dekervel, Dusan Popovic, Hannah van Malenstein, P Windmolders, Louis Libbrecht, Ashenafi Shiferaw Bulle, Bart De Moor, Eric Van Cutsem, Frederik Nevens, Chris Verslype
Pages: S404 - S404